Drug Chatter -- Tracking biopharma stock chatter

Profile for GlobeImmune, Inc. (GBIM)

« Back to company index

GBIM Chatter Timeline

Stock Ticker for GBIM

Most Active Tweeters for GBIM

UserTweets
@CatalystWatcher 6
@BoardCentral 1

Recent Tweets for GBIM

CatalystWatcher @CatalystWatcher
PSS + NantCell gone dark ahead of merger into NantBio & IPO it seems. Doubt $GBIM stays public much longer given its 200k NantCell shares.
September 22nd 2017, 12:09pm
CatalystWatcher @CatalystWatcher
At 2:02:50 into $BAVA presentation https://t.co/lgZxASaoOg , CMO clearly referring to efficacy seen in previous $GBIM GI-6301 trial.
September 21st 2017, 3:09pm
CatalystWatcher @CatalystWatcher
A look at NantCell acquisitions over 5 years. $GBIM only company not receiving initial investment but rather NantCe… https://t.co/mURbklOgh4
September 21st 2017, 9:09am
BoardCentral @BoardCentral
$GBIM "Altor and nk" on InvestorVillage message boards: https://t.co/y1P5SGqeYn
September 19th 2017, 6:09pm
CatalystWatcher @CatalystWatcher
$GBIM research scientist filled via LinkedIn. MC ~ $9 million with internal R&D & significant milestones for NantCell trials.
September 19th 2017, 10:09am
CatalystWatcher @CatalystWatcher
PSS could easily snag $GBIM here for $2.5 million market cap and save himself tens of millions in milestone payments.
September 18th 2017, 3:09pm
CatalystWatcher @CatalystWatcher
$GBIM officially hired Quality Control Specialist for manufacturing per linkedin...still hiring R&D for internal programs.
September 14th 2017, 12:09pm
pharma_sector @pharma_sector
#GlobeImmune Restarts Manufacturing. Read more: https://t.co/vvUzrSZL8q $GBIM
September 9th 2017, 7:09am
pharma_sector @pharma_sector
#GlobeImmune Provides Update On Recent Clinical Trial Developments . Read more: https://t.co/Nxn5S5kMWH $GBIM
September 9th 2017, 7:09am
pharma_sector @pharma_sector
#GlobeImmune Colorado biotech to restart operations at Louisville facility. Read more: https://t.co/R9hlPNVENX $GBIM
September 9th 2017, 7:09am
pharma_sector @pharma_sector
#GlobeImmune and NantCell work to advance tumor research. Read more: https://t.co/bDvrRn8iNL $GBIM
September 9th 2017, 7:09am
v1qtwJkLxv7zp5P @v1qtwJkLxv7zp5P
RT @BIGMONEYMIKE6: IM NOT EVEN GONNA LIE...... I LIKE DEPECHE MODE " JUST CANT GET ENOUGH " https://t.co/PoG1l38HhR $MGT $GBIM #BMM https…
September 8th 2017, 5:09pm
CatalystWatcher @CatalystWatcher
NantCell about to merge with NantOmics and NantBiosciences to form NantBio: https://t.co/Cqt454Rnu2 $GBIM owns 200k NC shares will merge too
September 8th 2017, 3:09pm
biotech_sector @biotech_sector
#GlobeImmune Restarts Manufacturing. Read more: https://t.co/1aFq2IkTsO $GBIM
September 8th 2017, 1:09pm
biotech_sector @biotech_sector
#GlobeImmune Provides Update On Recent Clinical Trial Developments . Read more: https://t.co/S9raWclrEU $GBIM
September 8th 2017, 1:09pm
biotech_sector @biotech_sector
#GlobeImmune Colorado biotech to restart operations at Louisville facility. Read more: https://t.co/Q56E1QRpKE $GBIM
September 8th 2017, 1:09pm
biotech_sector @biotech_sector
#GlobeImmune and NantCell work to advance tumor research. Read more: https://t.co/o22WeDI32e $GBIM
September 8th 2017, 1:09pm
CatalystWatcher @CatalystWatcher
@JamesCallaghanT Changes value of tender offer. $GBIM has 200k NantCell shares. All part of their IPO plan.
September 8th 2017, 12:09pm
CatalystWatcher @CatalystWatcher
$Gbim 110,000 share bid...
September 7th 2017, 10:09am
CatalystWatcher @CatalystWatcher
Having $GBIM as a separate comp. doesn't make sense as it could be a liability if there are 300 shrehldrs of record which forces SEC filings
September 1st 2017, 1:09pm
CatalystWatcher @CatalystWatcher
Long and strong. Holding $GBIM through the company's upcoming inflection point. Contrary to Tuesday's lies by a bas… https://t.co/CqjoU07v76
August 31st 2017, 3:08pm
CatalystWatcher @CatalystWatcher
The market may not be rationale, but it is efficient. I don't expect $GBIM to have a ~ $9 million market cap for much longer given update.
August 30th 2017, 3:08pm
Zoomlik1 @Zoomlik1
$gbim can't be gbim w/o JST and BNT family feud ...
August 29th 2017, 9:08pm
JSTBiotech @JSTBiotech
Some crazy cult $GBIM shareholders out there. I expose the truth today and they freak out. Expect stock to sell dow… https://t.co/5HYDeOL5Uf
August 29th 2017, 7:08pm
CatalystWatcher @CatalystWatcher
@moralesjohnp @JSTBiotech msg to me on Skype on Aug. 17 saying he would buy 100k $GBIM shares after LPTX news. Yet… https://t.co/i8etNI6YxZ
August 29th 2017, 6:08pm
moralesjohnp @moralesjohnp
Joel Thomson's brother told me that Joel (age 29) lives with his mom, doesn't pay rent and drives a new Lexus as a result $GBIM.
August 29th 2017, 6:08pm
CatalystWatcher @CatalystWatcher
Some serious slander and lies from @JSTBiotech today in $GBIM. I hope the company/SEC responds accordingly.
August 29th 2017, 5:08pm
SenorBrownCat @SenorBrownCat
@JSTBiotech I'd love to see it if you do find it. I have no horse in $GBIM but it'll be good to know for the future.
August 29th 2017, 1:08pm
moralesjohnp @moralesjohnp
$GBIM is also scheduled to receive royalty payments from NantCell based on product milestones from their current pi… https://t.co/npByPTh5GU
August 29th 2017, 1:08pm
JSTBiotech @JSTBiotech
@toronto_orlando One of the $GBIM longs disclosed to me his intentions of pumping/dumping stock. All I said was the truth
August 29th 2017, 1:08pm
CatalystWatcher @CatalystWatcher
Much better blocking him. Feel sorry for those who sold $GBIM on false, misleading and slanderous lies by an angry former shareholder.
August 29th 2017, 1:08pm
toronto_orlando @toronto_orlando
$GBIM is all this bashing going on so someone can get cheaper shares before the run up
August 29th 2017, 12:08pm
moralesjohnp @moralesjohnp
NantCell is still partnered with $GBIM per the update on company's website 8/28/2017. https://t.co/JcjOl9re0u
August 29th 2017, 12:08pm
CatalystWatcher @CatalystWatcher
Slander and libel are illegal. $GBIM. @JSTBiotech needs to be arrested
August 29th 2017, 12:08pm
CatalystWatcher @CatalystWatcher
$Gbim @JSTBiotech needs to be arrested for libel and slanderous accusations to manipulate stock priced. @SEC_Enforcement
August 29th 2017, 11:08am
JSTBiotech @JSTBiotech
I have proof that $GBIM was an orchestrated pump/dump scheme. Stock should be much lower
August 29th 2017, 11:08am
JSTBiotech @JSTBiotech
@CatalystWatcher privately telling me that he and a friend are currently working on a SeekingAlpha $GBIM pump/dump… https://t.co/ShJilW3XCV
August 29th 2017, 11:08am
JSTBiotech @JSTBiotech
NantCell in March bought 12,835,490 shares of new dilution from $GBIM at $0.16/share. Why pay more than they did? https://t.co/k3lbAsn8Lw
August 29th 2017, 10:08am
JSTBiotech @JSTBiotech
$GBIM current level 2 bids. Anyone pumping you to buy is doing so because there is no liquidity, AT ALL, for them t… https://t.co/Nzsmu8VYwa
August 29th 2017, 10:08am
JSTBiotech @JSTBiotech
$CELG terminated $GBIM license pact made public yesterday CC @JohnCendpts
August 29th 2017, 10:08am
JSTBiotech @JSTBiotech
$GBIM sold (diluted) 2/3 of the company in March for a $0.17 valuation. Don't fall for any pumps!
August 29th 2017, 10:08am
CatalystWatcher @CatalystWatcher
$GBIM closing in on $1. As yesterday's news spreads this will become a reality. https://t.co/CJ9ejoliEi
August 29th 2017, 10:08am
JSTBiotech @JSTBiotech
I will have plenty of things to say on $GBIM if/when a pump/dump article comes out.
August 29th 2017, 10:08am
JSTBiotech @JSTBiotech
I hear some $GBIM shareholders will try and pump stock with a seeking alpha article in the coming days, so they can sell. Don't fall for it!
August 29th 2017, 10:08am
CaesarBiotech @CaesarBiotech
$NK $GBIM GI-6100 licensing and QUILT trials Strong rationale between EMT-brachyury, MUC-1 and NK cells https://t.co/QzJMaPQSWV
August 29th 2017, 6:08am
pharma_sector @pharma_sector
#GlobeImmuneÂProvides Update on Recent Clinical Trial Developments. Read more: https://t.co/9tpzRIFn5y $GBIM
August 29th 2017, 4:08am
pharma_sector @pharma_sector
#GlobeImmune Globeimmune Inc Financial and Strategic SWOT Analysis Review Report Updated 0... Read more: https://t.co/QCiTXusTUu $GBIM
August 29th 2017, 4:08am
pharma_sector @pharma_sector
#GlobeImmune Provides Update on Recent Clinical Trial Developments. Read more: https://t.co/UlI4imxyhq $GBIM
August 29th 2017, 4:08am
pharma_sector @pharma_sector
#GlobeImmune and NantCell work to advance tumor research. Read more: https://t.co/GHoPqion8N $GBIM
August 29th 2017, 4:08am
biotech_sector @biotech_sector
#GlobeImmuneÂProvides Update on Recent Clinical Trial Developments. Read more: https://t.co/3drL3rsCzn $GBIM
August 29th 2017, 3:08am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.